electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. The event is scheduled for February 11-12, 2025 in Snowbird, Utah.

CEO Dan Goldberger will be available for one-on-one meetings throughout the conference. Interested investors can arrange meetings through their BTIG representative or by contacting electroCore's investor relations team directly at investors@electrocore.com.

News Market Reaction – ECOR

+1.86%

+1.86% Session move

In the trading session that priced this news, ECOR gained 1.86%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12^th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12, 2025 in Snowbird, Utah.

Dan Goldberger, Chief Executive Officer, will host one-on-one meetings throughout the conference. To schedule a one-on-one meeting with Mr. Goldberger, investors are encouraged out to their BTIG representative or contact the electroCore investor relations team at investors@electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact

ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

When is electroCore (ECOR) participating in the BTIG MedTech Conference 2025?

electroCore will participate in the BTIG MedTech Conference on February 11-12, 2025, in Snowbird, Utah.

How can investors schedule meetings with electroCore (ECOR) at the BTIG Conference?

Investors can schedule one-on-one meetings with CEO Dan Goldberger through their BTIG representative or by contacting electroCore's investor relations team at investors@electrocore.com.

What type of meetings will electroCore (ECOR) offer at the 2025 BTIG Conference?

electroCore will offer one-on-one meetings with CEO Dan Goldberger throughout the conference.

Where is the 2025 BTIG MedTech Conference being held for electroCore (ECOR)?

The 12th Annual BTIG MedTech Conference is being held in Snowbird, Utah.